2016 total revenue increased 45 percent Provides update on Makena® next-generation program Anticipates 2017 GAAP revenue of $620-$670 million, including Makena net sales of $410-$440 million WALTHAM, Mass., Jan. 09, 2017 (GLOBE NEWSWIRE) -- AMAG …
PHILADELPHIA and OXFORD, United Kingdom, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that GlaxoSmithKline plc (NYSE:GSK) (LSE:GSK) has nominated a second target, …
PHILADELPHIA and OXFORD, United Kingdom, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that Mark E. Dudley, Ph.D. has joined the company as Senior Vice President of …
Online car inventory marketplace announces innovative customization tool to further enhance its vehicle deal generation experience AUSTIN, TEXAS, USA, January 9, 2017 /EINPresswire.com/ -- KosLo, the online vehicle deal generation company that is …
SPARTANBURG, S.C., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Denny’s Corporation (NASDAQ:DENN), franchisor and operator of one of America's largest franchised full-service restaurant chains, today reported preliminary results for domestic same-store sales and …
PHILADELPHIA and OXFORD, United Kingdom, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that the US Food and Drug Administration (FDA) has accepted the Company’s …
BERKELEY, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today a clinical collaboration with Merck (known as MSD outside the United States …
GLENVIEW, Ill., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Illinois Tool Works Inc. (NYSE:ITW) will issue its fourth quarter and full-year 2016 results at 7 a.m. (CST) on Wednesday, Jan. 25, 2017. Following the release, ITW will hold its fourth quarter and full- …
GREENSBORO, NC, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, has introduced a new family of 5 GHz and 2.4 GHz Wi-Fi Front-End Modules (FEMs) that pave the way for smaller, …
SAN DIEGO, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today provided a corporate update. As of yesterday, 38 …
FDA discussions on sparsentan planned for January; RE-024 advancing with Phase 3 trial for the treatment of PKAN Preliminary Full-Year 2016 Revenue of Approximately $134 Million SAN DIEGO, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ:RTRX) …
NEW YORK, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Progyny, a leading reproductive health technology and services company, today announced the appointment of former WebMD CFO, Peter Anevski, as its Chief Financial Officer and Chief Operating Officer. He joins …
JLT Specialty USA welcomes another team member to its Financial Institutions practice in New York NEW YORK, Jan. 09, 2017 (GLOBE NEWSWIRE) -- JLT Specialty USA, a U.S. subsidiary of Jardine Lloyd Thompson Group plc. (JLT), one of the world’s leading …
- Company Achieves In Vivo Proof-of-Editing in the Retina of Non-Human Primates - - Unparalleled Genome Editing Platform Includes Cpf1 and Advanced Forms of Cas9 - CAMBRIDGE, Mass., Jan. 09, 2017 (GLOBE NEWSWIRE) -- In a presentation to …
Two Phase 3 trials completed for Rekynda; co-primary endpoints met Will address underserved medical condition with significant untapped market potential Broadens AMAG’s presence in women’s health and leverages AMAG’s commercial capabilities and customer …
-- Biospecimens enriched with deep data insights for population analytics, prospective patient tracking and more -- CAMBRIDGE, Mass., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Novaseek Research LLC today announced that its Clinical Data Network for Research (CDNR) …
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will present at the 35th Annual J.P. Morgan …
2016 marks the third consecutive year of record passenger traffic 10 airports also reached record passenger levels 8 airports had double digit traffic growth in the year The Monterrey airport served 9.2 million passengers in 2016 MONTERREY, Mexico, Jan. 09 …
-- Expands Allergan’s Innovative GI Pipeline with ABI-M201 and ABI-M301, Preclinical Compounds Targeting Ulcerative Colitis and Crohn’s Disease, as well as Future Compounds for Irritable Bowel Syndrome -- DUBLIN, Ireland and INDIANAPOLIS, Jan. 09, 2017 ( …
LAS VEGAS, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq:LIVE) (“Live Ventures” or the “Company”), a diversified holding company, distributed the below Letter to its stockholders this morning: Dear Stockholders, As we begin the 2017 …
02 days 23:14:49
